Oncology ESMO25: On radiopharmaceutical possibilities in oncology, wi... At ESMO 2025, pharmaphorum spoke with Dr Ebrahim Delpassand, CEO of RadioMedix.
Digital Future-Proofing Health Systems: Insights from Frontiers Heal... At Frontiers Health 2025, we caught up with Moredreck Chibi (World Health Organization) and Chrys Herrera (Merck KGaA).
Patients Where Patients Lead: Insights from Frontiers Health 2025 At Frontiers Health 2025, patient advocate Silvia Cerolini (Eyes on the Future) opened the conference by sharing her story.
Oncology ESMO25: On allosteric modulation in oncology, with Michael L... At ESMO 2025, pharmaphorum had the pleasure of speaking with Michael Lahn, Chief Medical Officer at iOnctura.
Digital Veeva Commercial Summit: On AI, content, and MLR Review with... At Veeva Commercial Summit 2025 in Madrid, web editor Nicole Raleigh sat down with Emma Hyland – Vice President, Commercial Content Strategy, Europe.
Oncology ESMO25: Harnessing the innate and the adaptive immune respon... As ESMO 2025 came to a close last month, pharmaphorum had the pleasure of catching up with Dr Sandeep Reddy, Chief Medical Officer at ImmunityBio.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
